Company Search:
Advanced Search
Sponsored Links
Cellectis SA Company Snapshot
Cellectis SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellectis SA with three other companies in this sector in France: Innate Pharma S.A. (2017 sales of 32.63 million Euro [US$36.83 million] of which 100% was Licensing Revenue), Eurofins-Cerep SA (24.41 million Euro [US$27.55 million] ), and Adocia SAS (19.47 million Euro [US$21.97 million] of which 100% was Regenerative Medicine).

Sales Analysis. Cellectis SA reported sales of 29.60 million Euro (US$33.41 million) for the year ending December of 2017. This represents a sharp decrease of 42.0% versus 2016, when the company's sales were 51.01 million Euro. Contributing to the drop in overall sales was the 41.9% decline in Therapeutics, from 53.73 million Euro to 31.24 million Euro. . However, these declines were partially offset by the increase in sales of Plants (up 24.0% to 802,364.04 Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cellectis SA
  Stock Performance Chart for Cellectis SA
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 15.14
(Figures in Euro)
1 Week 1.4%   13 Weeks 2.6%  
4 Weeks -20.6%   52 Weeks -42.7%  
Cellectis SA Key Data:
  Ticker: ALCLS Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 29,597,050
(Year Ending Jan 2018).
Employees: 135
  Currency: Euro Market Cap: 641,952,684
  Fiscal Yr Ends: December Shares Outstanding: 42,401,102
  Share Type: Action Ordinaires Closely Held Shares: 10,480,419
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.